XOSPATA Speaker Program
Loading Map....
XOSPATA® (gilteritinib): A Targeted Therapeutic Approach for Relapsed/Refractory FLT3m+ AML
PRESENTER
HAIFAA ABDULHAQ, MD
Teaching Faculty, Hematology/Oncology
Director, Hematology
Central California Faculty Medical Group